NetworkNewsBreaks – TC Biopharm (Holdings) PLC (
Post# of 10
(Total Views: 50)
Posted On: 09/23/2024 4:05:45 PM
NetworkNewsBreaks – TC Biopharm (Holdings) PLC (NASDAQ: TCBP) Completes ACHIEVE Trial Full-Dose Regimen for First Patient
TC Biopharm (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, has announced a key step in its ACHIEVE clinical trial. According to the announcement, the first patient has completed the full-dose regimen in the phase 2b trial. In addition, the company announced that six patients have received a second dose and three patients have received a third dose; patients can receive up to four total doses of TCB under the trial protocol. Furthermore, no TCB008-related adverse events have been observed in any of the restart patients.
NOTE TO INVESTORS: The latest news and updates relating to TCBP are available in the company’s newsroom at https://nnw.fm/TCBP
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
TC Biopharm (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, has announced a key step in its ACHIEVE clinical trial. According to the announcement, the first patient has completed the full-dose regimen in the phase 2b trial. In addition, the company announced that six patients have received a second dose and three patients have received a third dose; patients can receive up to four total doses of TCB under the trial protocol. Furthermore, no TCB008-related adverse events have been observed in any of the restart patients.
NOTE TO INVESTORS: The latest news and updates relating to TCBP are available in the company’s newsroom at https://nnw.fm/TCBP
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
(0)
(0)TC BioPharm Holdings Plc (TCBP) Stock Research Links
Scroll down for more posts ▼